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Abstract: The multiple modes of SARS-CoV-2 transmission including airborne, droplet, contact,
and fecal–oral transmissions that cause coronavirus disease 2019 (COVID-19) contribute to a public
threat to the lives of people worldwide. Herein, different databases are reviewed to evaluate modes
of transmission of SARS-CoV-2 and study the effects of negative pressure ventilation, air conditioning
system, and related protection approaches of this virus. Droplet transmission was commonly reported
to occur in particles with diameter >5 µm that can quickly settle gravitationally on surfaces (1–2 m).
Instead, fine and ultrafine particles (airborne transmission) can stay suspended for an extended
period of time (≥2 h) and be transported further, e.g., up to 8 m through simple diffusion and con-
vection mechanisms. Droplet and airborne transmission of SARS-CoV-2 can be limited indoors with
adequate ventilation of rooms, by routine disinfection of toilets, using negative pressure rooms, using
face masks, and maintaining social distancing. Other preventive measures recommended include
increasing the number of screening tests of suspected carriers of SARS-CoV-2, reducing the number
of persons in a room to minimize sharing indoor air, and monitoring people’s temperature before ac-
cessing a building. The work reviews a body of literature supporting the transmission of SARS-CoV-2
through air, causing COVID-19 disease, which requires coordinated worldwide strategies.
Keywords: coronavirus; COVID-19; infection; SARS-CoV-2; pandemic
1. Introduction
The rapid outbreak of coronavirus disease 2019 (COVID-19) caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) that is spread via airborne, droplet, con-
tact, and fecal–oral transmission modes constitutes a worldwide and disruptive challenge
to societies [1,2]. Both symptomatic and asymptomatic carriers have been recognized to
transmit the SARS-CoV-2 virus via various modes of transmission [3–5], causing severe
respiratory infections among patients receiving medical care in hospitals [6–11]. Hence,
the COVID-19 outbreak has been declared a global public health emergency of international
concern by the World Health Organization (WHO) [12–14]. The original source and the
way of transmission to humans are the subject of current studies [13,15–17]. It was stated in
January 2020 that the virus of SARS-CoV-2 causes COVID-19, creating infections typical for
a second-class infectious disease, but that management measures for a first-class infectious
(dangerous) disease are required [12]. At least a 70% genetic similarity of SARS-CoV-2 to
the original Severe Acute Respiratory Syndrome (SARS), as well as it being a subspecies of
Sarbecovirus, has been reported [18,19].
Coronaviruses such as SARS, endemic human coronaviruses (HCoV), and Middle East
Respiratory Syndrome (MERS) can remain biologically active for ≤9 days on the surface
Int. J. Environ. Res. Public Health 2021, 18, 395. https://doi.org/10.3390/ijerph18020395 https://www.mdpi.com/journal/ijerph
Int. J. Environ. Res. Public Health 2021, 18, 395 2 of 18
of plastic, metal, and glass [19]. Because the incubation time of SARS-CoV-2 vary from 2
to 14 days, infected persons not displaying symptoms and unaware of their infection are
active carriers for transmission to others [12,13,15,16]. Generic symptoms of COVID-19
disease are common to SARS and MERS infections including fatigue, nausea, diarrhea,
vomiting, breathing difficulty, dry cough, fever, and bilateral lung infiltration in severe
cases [13,18,20].
On 7 February 2020, COVID-19 cases existed in twenty-six countries around the world:
Canada, the United States, Australia, India, Sri-Lanka, Cambodia, Thailand, Vietnam,
Malaysia, Singapore, Taiwan, South Korea, Japan, Philippines, Nepal, United Arab Emi-
rates, Russia, Italy, Germany, Sweden, Finland, Belgium, Spain, France, and the United
Kingdom [9,10]. Most of the confirmed cases were travelers connected to Wuhan or
other Chinese cities; however, locally transmitted cases outside of China had also been
reported [10]. Moreover, respiratory transmission of the novel coronavirus by airborne
mechanisms from aerosols and droplets gained consideration [21–25]. SARS-CoV-2 can
be spread via near contact with an infected person coughing or sneezing and emitting
small droplets [21,26–28]. Transmission via droplets occurs when a SARS-CoV-2 carrier
talking, coughing, and sneezing emits droplets with the virus that can expose other peo-
ple’s nose, mouth, and eyes causing infection [24]. Those generated droplets are relatively
large and cannot stay in the air for long time and deposit relatively rapidly [24,29–31].
Hence, near contact with an infected person is the main way for virus intake causing
infection [9,20,22–24,30–32].
In addition, indirect long-distance transmission (aerosol transfer) is possible and can
happen [9,33–35]. The virus emitted in small particles may be transferred a long-distance [9].
In other words, airborne transmission by small droplet nuclei or particulates including
the virus is favored due to their extended time suspended in air, and their farther distance
traveled from the emitter [24]. For example, concentrated airborne droplets (fragmented)
are released through respiration or from sneezing by patients with SARS-CoV-2 virus,
reaching several meters away to also remain in suspension for about 30 min, and once
settled onto objects can still be biologically active for a few days [22,36].
Because there is no specific therapeutic drug or vaccine for COVID 19 yet [20,37–42],
it is important to reduce exposure to SARS-CoV-2 [9]. Thus, specific control measures for
SARS-CoV-2 transmission are needed [43–46], such as those listed by the US Centers for
Disease Control and Prevention (CDC). The CDC measures include suitable sanitary habits
such as utilizing regular hand washing with soap and water, or an alcohol-based hand
rub (ABHR) with at least 60% alcohol, using protective masks in public, restricting social
contacts (restricting human to human transmission pathway), cleaning and disinfecting
surfaces continuously, staying at home as much as possible, and applying proper venti-
lation such as displacement ventilation (DV) to decrease infection risk [6,9,13,20,47–49].
Wearing protective masks in public is perhaps the most cost-effective way for prevent-
ing to SARS-CoV-2 spreading. However, temporary shortages in supply of facemask
have occurred during the outbreak of COVID-19 due to limitations in production and
import/export of KN95/N95 respirators and medical protective masks [10,23,50].
Aim
To the best of our knowledge, this is the first study reviewing the recent literature for
SRAS-CoV-2 transmission by grouping them into four structured sections that including
an introduction, a methodology section, the results and discussion, and the concluding
remarks. The work explains common symptoms of COVID-19, modes of transmission of
SARS-CoV-2, concentration, and infectious dose for airborne transmission of SARS-CoV-
2, the influencing factors on the airborne transmission of SARS-CoV-2, and protection
approaches to prevent the transmission of SARS-CoV-2. Finally, several proposed protocols
for SARS-CoV-2 prevention and a future perspective of the current situation are presented.
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2. Method
2.1. Design
This work originated from a systematic review to provide a narrative synthesis per-
formed according to the Preferred Reporting Items for Systematic Reviews and Meta-
analysis (PRISMA) statement [51].
2.2. Search Strategy
To perform this work, papers appearing in international databases (Medline/PubMed,
Scopus, Google Scholar, Web of Sciences, Science Direct, and Embase) were identified
by the following keywords: coronavirus, coronavirus disease 2019, COVID-19, personal
protective equipment, transmission, airborne, contact, fecal–oral, droplet, outbreak, beta-
CoVs, respiratory, SARS-CoV-2, bioaerosol, aerosol, airborne particle, air, negative pressure,
ventilation, air conditioning, social distancing, N95 respirator, mask, alcohol, facemask,
ambient air, and indoor air. Due to the high number of articles and to keep the literature
up to date, the search was constrained on articles published between 1 March 2020 and
28 December 2020.
2.3. Inclusion Criteria
In addition, preference was given to papers in journals that provide information
in the field of airborne and droplet transmission of SARS-CoV-2 virus; the effects of
different factors such as environmental conditions, negative pressure ventilation (NPV),
air conditioning system, displacement ventilation (DV), noninvasive positive pressure
ventilation (NIPPV), and high-flow nasal cannula (HFNC) on the airborne transmission of
SARS-CoV-2; and effects of protection approaches for transmission of SARS-CoV-2.
2.4. Exclusion Criteria
The papers with the following contents were considered to be out of the scope of
this review and therefore removed: (i) the epidemiology, virology, and clinical features
(imaging features) of SARS-CoV-2; (ii) the transfer of SARS-CoV-2 via wastewater (sewage)
and solid waste; and (iii) the effects of COVID-19 on the mental health and quality of
people’s life, culture, education, politics, and economy of countries.
3. Results
Results of the Structured Literature Review
First, the titles and abstracts of articles were examined. Then, the investigation was ex-
tended to study the full text of related articles as define above. Finally, the selected articles
in the field of transmission modes of bioaerosols such as SARS-CoV-2 were studied. As il-
lustrated in Figure 1, the search strategy produced 297 records. The result set was reduced
to 215 records following removal of duplicate and non-English language records. The focus
of this research was limited to studies on the airborne, droplet, contact, and fecal–oral trans-
missions of SARS-CoV-2; the effects of environmental conditions (e.g., relative humidity,
temperature, and evaporation), NPV, DV, air conditioning system, NIPPV, and HFNC on
the airborne transmission of SARS-CoV-2; and protection approaches for transmissions
of SARS-CoV-2. Based on a review of the abstracts for relevance, we excluded 83 records.
After reading the methods and results sections of the 132 remaining reports, we excluded
six reports that did not meet our inclusion criteria: three were the epidemiology and clinical
features of SARS-CoV-2 and three were wastewater (sewage) studies. Thus, 126 individual
reports were included in our work. The search findings are shown in Figure 1 as a PRISMA
flow chart.
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mon cold [47,52,53]. Meanwhile, the novel coronavirus (SARS-CoV-2) causes severe
respiratory illness (lungs and upper respiratory tract) and even de th in some patients
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(Figure 2) [15–17,20,27,47,54]. It should be noted that SARS-CoV-2 belongs to beta-CoVs,
and its size is between 60 and 140 nm [55] and approximately 120 nm in diameter [56].
Moreover, some studies reported that SARS-CoV-2 has a zoonotic origin [15–17,20,27,47,54].
Common signs of this disease are fever, dyspnea, cough, and fatigue, while less
usual signs consist of diarrhea, sputum production, hemoptysis, and headache [10,16,57].
In addition, previous studies demonstrated that COVID-19 can cause pneumonia, kidney
failure, severe acute respiratory syndrome, and even death [16,58,59]. Besides, Deng et al.
(2020) reported that the main symptoms experienced by forty-five fatal cases included
shortness of breath, chest pain, fever, and cough [37]. Various symptoms of COVID-19 that
can be expressed from 2 to 14 days after infection including fever, cough, and shortness of
breath and can become severe enough to result fatal to some patients [38,60–62].
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Figure 2. Conceptualization of SARS-CoV-2 deposition: (a) once infected with novel coronavirus,
viral particles get in the lungs and upper respiratory tract; (b) transmission of SARS-CoV-2 via
droplets and aerosolized viral particles when COVID-19 patients talking, coughing, breathing,
singing, and sneezing and can distribute on the other people’s nose, mouth, eyes, clothes, and nearby
surroundings; (c) SARS-CoV-2 from the mouth and nose is often observed on the hands; and (d) SARS-
CoV-2 could be distributed to often touched surfaces and objects [63].
Chhikara et al. reported that patients with COVID-19 displayed all symptoms of this
disease within 2–7 days [57], and the WHO reported that some patients have a mild sore
throat, fever, cough, and a runny nose, while others suffer severe symptoms with breathing
difficulties and pneumonia leading to death [20].
4.2. Modes of Transmission of SARS-CoV-2
4.2.1. Droplet Transmission
Respiratory transmission of the SARS-CoV-2 can occur by droplet transmissions [5,22–24,32].
Transmission via droplets happens when carriers of the virus talking, coughing, breath-
ing, singing, and sneezing emit bioaerosol particles that can reach other people’s nose,
mouth, and eyes causing infection (Figure 2) [24]. In addition, Holland et al. reported
that, similar to influenza, mumps, Haemophilus influenzae, whooping cough, and rubella,
coronaviruses are transmitted by bioaerosol droplets [24]. Furthermore, Abkarian et al.
and Chong et al. described how flows generated during speaking, singing, breathing, and
laughing by asymptomatic and presymptomatic humans contribute to the sprea of SARS-
CoV-2 virus [4,5]. In addition, experime ts and simulations were performed o quantify
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how exhaled air is transferred during talking and stressed that phonetic characteristics add
complexity to the airflow dynamics, i.e., plosive sounds, such as certain words starting
with the letter “P” in English, create intense vortical structures that act as “puffs” and
quickly reach 1 m distances [4]. Moreover, speech corresponding to a train of such puffs can
make a conical, turbulent, jet-like flow and generate directed transport more than 2 m away
in 30 s of conversation [4]. Bourouiba et al. illustrated that, depending on the patient’s
physiological composition (droplets of mucosalivary liquid emissions associated with hot
and moist air) and meteorological conditions (humidity and temperature), the gas cloud
and its payload of pathogen-bearing droplets in any size can be transmitted up to 8 m [64].
Along the way, droplets of any size can settle out or evaporate at rates that depend not only
on their size but also on the degree of turbulence and velocity of the gas cloud, along with
the properties of the ambient environment (temperature, humidity, and air flow) [64–66].
Chong et al. reported that smaller respiratory droplets (<10 µm) have the tendency to be
taken via the turbulent puff and travel together with the fluid. This can result in an increase
of smaller relative velocities and less evaporation owing to the reduction of convective
effects, while larger respiratory droplets falling out from the puff settle more quickly than
the surrounding fluid [5].
According to pervious work, bioaerosol droplets with different particle size are
generated by people [32,67]. Produced bioaerosol droplets in common breathing are
in the 0.8–2 µm range, whereas for speaking bimodal distributions in the 16–125 and
0.8–7 µm ranges [32]. Likewise, coughing creates particles from 0.6 to 16 and 40 to 125 µm,
while sneezing mostly from 7 to 125 µm [32]. Additionally, previous works stated that
produced bioaerosol droplets in coughing and sneezing can range from <1 to >500 or
<2000 µm (or many aerosols) [67–69].
Stariolo provided two models for the time that generated bioaerosol droplets remain in
undisturbed air [23]. In Model 1, droplets with size higher than 200 µm are determined not
to be a health risk if social distancing about 1.5–3 m is practiced to avoid SARS-CoV-2 trans-
mission from expiratory activities such as coughing, talking, and sneezing [23,32,49,70].
For droplets <100 µm, a second model of motion in viscous air was employed [23]. In addi-
tion, other authors stated that droplet transmission occurred from particles larger than 5 µm,
which can underdo gravitational settling on surfaces [9,71] (Figure 2). Because gravitational
settling of these particles occurs within 1 m, a cautionary distance of 2 m is considered an
appropriate preventive measure (Figure 3) [9,45,71]. Furthermore, to diminish the numbers
of COVID-19 cases, it is necessary to slow down the transmission of the life-threatening
SARS-CoV-2 virus via virus-laden droplets from screaming, shouting, speaking, breathing,
singing, sneezing, or even coughing. Hence, for reducing infections via such respiratory
droplets, governments around the world have offered the so-called “2-m distance rule” or
“6-foot rule” [1,5].
Many studies assumed that generated bioaerosol droplets from people (e.g., droplets
produced by talking, coughing, breathing, singing, and sneezing) are relatively large
(0.6–2000 µm), remain in air for short time, and are deposited relatively rapidly [24,29–31].
However, those works recognized the transmission of SARS-CoV-2 by bioaerosol droplets
can proceed.
4.2.2. Contact Transmission
The contact transmission of SARS-CoV-2 can happen from surfaces and objects con-
taminated with SARS-CoV-2 (Figure 2d), where viruses can remain viable to cause infection
for several hours and even days [71,72]. For instance, according to Figure 4, SARS-CoV-
2 can survive 2–9 days on the surfaces and objects such as plastic (≥4 days), metal (5
days), wood (4–5 days), gowns (2 days), latex gloves (≤8 h), paper (1–5 days), and glass (4
days) [73].
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For example, Fiorillo et al. reported that various coronaviruses survive on infected
surfaces for up to nine days, and disinfecting infected surfaces with 62–71% ethanol for
1 min or 0.1% sodium hypochlorite can eliminate coronaviruses [74].
In other words, efforts to prevent SARS-CoV-2 transmission by contact with the
infected surface or objects (fomite transmission) are also important [9]. For example,
the SARS-CoV-2 could also be attached to clothing and distributed by contact [9,26–28],
putting at high risk the front-line healthcare workers (HCWs) and communities at large [35,71].
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4.2.3. Fecal–Oral Transmission
Special attention should be paid to the possibility of fecal transmission, as SARS-CoV-2
has recently been observed in the feces of infected people [9]. Furthermore, Yang and Wang
(2020) reported that the SARS-CoV-2 has been observed in the feces of patients, which
may pollute aquatic environments and also cause a fecal–oral route of transmission [13,75].
In addition, previous work reported that the bioaerosols released from the infectious feces
from COVID-19 patients can create infection [9,13,75]. According to Xu et al. and Liao
et al., airborne aerosol transmission of SARS-CoV-2 is possible from sewage including
fecal matter from carrier persons [9,76]. Airborne aerosol transmission of SARS-CoV-2 is
described in Section 4.2.4.
4.2.4. Airborne Transmission
Although bioaerosol was a common term applied for microorganisms suspended in
indoor or ambient air [77–80], in medical terminology, bioaerosols are airborne particles
with biological matter [32,81]. The mechanism of airborne transmission involves small
droplet nuclei (fluid of pathogenic droplets) or particulates including the virus that can stay
suspended in air for an extended period of time (≥2 h) and can move farther distances from
carriers of SARS-CoV-2 [24]. For example, concentrated airborne droplets (fragmented)
that are released during respiration or sneezing by SARS-CoV-2 carriers, may move several
meters (up to 8 m), stay suspended for about 30 min, and remain viable on objects for a few
days [22,36]. In addition, Lednicky et al. reported that viable SARS-CoV-2 was isolated
from air samples gathered 2–4.8 m away from patients [82].
According to the WHO, airborne transmission is possible by virions in droplet nuclei
<5 µm that can be present in air for extended periods of time traveling distances >1 m [29].
Airborne transmission by particles <5 µm can distribute SARS-CoV-2 through the air for
several hours [71,83,84]. Furthermore, Lee (2020) reported that the minimum size of a
respiratory particle that can include SARS-CoV-2 is computed to be about 4.7 µm [85].
The WHO recently suggested that airborne transmission of SARS-CoV-2 can occur in
special conditions and settings such as “cardiopulmonary resuscitation (CPR), endotracheal
intubation, bronchoscopy, open suctioning, positive pressure ventilation, high-flow nasal
cannula (HFNC), and manual ventilation before intubation”, which in this situations may
create aerosols [29,71,86]. The question then arises: “Is it likely that the SARS-CoV-2
spreads by air?” [45].
The WHO has not established the importance of airborne transmission of SARS-CoV-2.
Thus, official measures by governments such as that of Italy still recommend keeping a
distance of just 1 m (red zone) [87,88] because long-range spreading of SARS-CoV-2 is
ignored. Hence, how can the daily increase in the number of COVID-19 cases in the United
States and Italy be justified? [45]. The complexity to establish the presence of virions in air
may have delayed establishing this transmission route [45]. Importantly, it is a well-known
that SARS-CoV-1 was spread via aerosol particles in air [32]. Furthermore, many similarities
between SARS-CoV-1 and SARS-CoV-2 and their symptoms were reported, suggesting the
high likelihood for SARS-CoV-2 airborne transmission [45,89]. The COVID-19 pandemic
could then share a common airborne transmission mechanism with tuberculosis and
varicella, which is more effective than droplet transmission [24,32,90].
Hence, the final answer to the question is that, due to the increasing trends of infection
with SARS-CoV-2 around the world, and knowing the basic science of viral infection spread,
there are strong reasons for researchers to believe that SARS-CoV-2 is spreading via the
air [45]. In other words, airborne transmission is an important mechanism for the fast
spreading of SARS-CoV-2 [24,32,45,91]. In this context, the existing compelling evidence
calls for reconsidering only direct contact transmission as the main way of a viral infection.
The airborne transmission route should not be ignored by government officials but become
a serious concern during the epidemic [45,92].
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4.3. Concentration and Infectious Dose for Airborne Transmission of SARS-CoV-2
The load of SARS-CoV-2 RNA in suspended particles for potential airborne transmis-
sion was investigated by Liu et al. for patient and medical staff areas of Renmin hospital
of Wuhan University and Wuchang Fangcang Field hospital and public areas in Wuhan.
They collected 35 samples and discriminated by size (total suspended particle, size segre-
gated, and deposition aerosol) [46]. The aerosol fraction was divided into five sizes that
included: 0–0.25 µm, 0.25–0.5 µm, 0.5–1 µm, 1–2.5 µm, and ≥2.5 µm [46]. The results
show that the RNA concentration of SARS-CoV-2 aerosol in various areas of Fangcang
hospital were 1–9 copies/m3 [46]. The highest concentration of SARS-CoV-2 RNA for
both hospitals was about 19 copies/m3 and found in the patient mobile toilet room [46].
Furthermore, considerable levels of SARS-CoV-2 RNA was detected in two definite size
ranges: submicron particles (0.25–1.0 µm) with concentrations 9 and 40 copies/m3 and
supermicron particles (>2.5 µm) with concentrations 7 and 9 copies/m3 [46]. Deposition
aerosol samples gathered from intensive care unit (ICU) rooms of Renmin hospital showed
SARS-CoV-2 RNA concentrations from 31 to 113 copies/m2 per hour, and the maximum
deposition rates were found in the hindrance-free corner of the room (3 m from the patient’s
bed) [46].
Guzman pointed out that the submicron and supermicron aerosols carrying pathogens
can coexist owing to the different production routes and resuspension creating supermicron
particles that included pathogens from the objects such as protective equipment and shoes
producing secondary aerosols [32,46]. Supermicron particles including SARS-CoV-2 can
settle on the nasopharyngeal area, pass via the mucous membranes, and replicate to
continue distributing to other tissues and organs, including the lungs [32,93]. Furthermore,
2.5–5 µm particles can settle on the trachea, whereas particles ≤2.5 µm (fine particles) and
≤0.1 µm (ultrafine particles) can reach the lungs tissues and settle in the alveolar ducts
and sacs [32,94]. Such particles can contribute to the direct transmission of SARS-CoV-2;
otherwise, it would be difficult to explain how ten individuals from three families eating
at the same restaurant in Guangzhou (China) became sick with COVID-19, unless there
was a contribution to the spreading of exhaled particles <5 µm in size by air-conditioned
ventilation [32,94]. In addition, in agreement with the perspective of Guzman, Cervino
et al. reported that healthcare workers may transmit the viable virus from the floor of one
ward to another on their shoes [1,32,95].
Particular care must be taken of reemitted copies of the virus that had settled on the
protective clothes of medical workers and floor surface during long time, which can be
aerosolized by moving objects and stepping on floors [32,46]. Thus, following recommenda-
tions for sanitization of surfaces, protective equipment and clothing is crucial for reducing
aerosol transmission of SARS-CoV-2 [32,46]. The infectious dose of SARS-CoV-2 is believed
to be low (1 × 102 to 1 × 103 particles) due to the fast distribution ability of the virus around
the world [32,45,96,97]. Hence, it is imperative for researchers to evaluate how low the
concentration of virus, for different particle sizes, may lead to infection [32,91]. For instance,
scanning electron microscopy (SEM) works of gathered aerosol samples demonstrated the
virion integrity of SARS-CoV-2 may be kept more than 16 h suspended in the air [32,91].
4.4. Influencing Factors on the Airborne Transmission of SARS-CoV-2
4.4.1. Environmental Conditions
Various parameters such as relative humidity, temperature, and evaporation affect the
transmission of SARS-CoV-2 [32,45,48,71,98–100]. Yao et al. described a decrease of SARS-
CoV-2 transmission at high temperature and low relative humidity for ambient ozone
levels [48]. While large droplets including virus are deposited on near surface, if liquid
content of the same virus-laden particles is loss to air by evaporation, those resulting
smaller airborne particles can move via air current rather than by gravitational settling [45].
The evaporation of water droplets <10 µm occurs in less than 1 s, leaving nuclei that may
include virions suspended in air for several hours (e.g., for transmission in hospital rooms
and interior of airplanes) [23]. In addition to simple diffusion in quiet air, the convection
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process is surely another main method for airborne infection. It has been described that,
even in the presence of convective flows, the virus can distribute to a large room before
settling or scattering on surfaces [23]. Furthermore, Chong et al. reported how variable
environmental conditions such as a raise in relative humidity from 50% to 90% can extend
the lifetime of droplets with 10 µm diameter and affect airborne transmission of SARS-
CoV-2 over large distances [5]. They also stressed that smaller droplets live longer and
travel farther than large droplets [5]. By tracking Lagrangian statistics, Ng et al. reported
that cold and humid environments reduce the ability of air to keep water vapor, leading
to the respiratory vapor puff to supersaturate [101]. As a result, the supersaturated vapor
field drives the growth of droplets that are caught and transported within the humid
puff [101]. Hence, droplets smaller than 10 µm can reach farther distances when the
weather is cold and humid [101]. In addition, Chaudhuri et al. described that, as the
droplet evaporation time specifies the infection rate constant, environmental conditions
affect the COVID-19 outbreak growth rates [102]. Although warm weather can reduce
the growth rates, rigid social enforcement measures are also needed together with contact
tracing, quarantining, and the widespread use of face masks to control the COVID-19
pandemic [102].
Cervino et al. reported the remarkable persistence of the virus at low temperature [95].
For example, after fourteen days at 4 ◦C, the viral titer was reduced only by 0.7 logarithmic
units [95]. Instead, by increasing the incubation temperature to 70 ◦C, the virus was no
longer detectable after only 5 min [95]. Moreover, changes in pH did not affect the stability
of SARS-CoV-2, as studied in the range from pH 3 to 10 [95].
4.4.2. Negative Pressure Ventilation (NPV), Displacement Ventilation (DV), Air Conditioning
System, Noninvasive Positive Pressure Ventilation (NIPPV), and High-Flow Nasal
Cannula (HFNC)
Santarpia and coauthors collected air samples from eleven isolation rooms at the Uni-
versity of Nebraska Medical Center (including thirteen COVID-19 patients) for examining
viral shedding from patients. They showed that SARS-CoV-2 was poured into the air as
expired particles, during toilet flushing and via contact with fomites. They concluded that
SARS-CoV-2 can be transmitted directly from patients by droplets and indirectly from air
and polluted contacts [103]. The same study detected SARS-CoV-2 RNA using real-time
reverse transcriptase–polymerase chain reaction (RT-PCR) and reported the mean concen-
tration of 2.86 copies/L of air (63.2% positive) in patient rooms. The previous observation
indicated the transmission of aerosols could have occurred even in the absence of cough or
aerosol producing ways because samples were collected in rooms with negative pressure
ventilation (NPV) [103]. They interpreted that air turbulence can lead to suspend the
droplets with large size for a long time in isolation rooms [103]. However, further Tan et al.,
Liu et al., Vukkadala et al., Cook, Holland et al., and Fathizadeh et al. discussed an opposite
scenario and mentioned that, to prevent SARS-CoV-2 transmission, patients should be
kept in negative pressure rooms as much as possible [24,46,71,73,104,105]. For example,
Tan et al., the CDC, and Holland et al. declared that, to keep particles with SARS-CoV-2
from escaping the areas with infected patients, rooms under negative pressure should be
used [24,104,106].
Air conditioning systems have been considered to be just as important as negative
pressure ventilation (NPV) systems. Air conditioning of contaminated rooms must be
exercised under negative pressure mode due to the fact that those rooms apply lower air
pressure to permit outside air into the divided environment, keeping harmful particles
from escaping to ambient air [45,46,71,73].
Previous works described that patients rooms with NPV and high air-exchange rates
in different parts of Renmin Hospital were useful for reducing airborne transmission of
SARS-CoV-2 [46,73]. In addition, Chiu and co-authors mentioned that endoscopies in cases
of suspected or confirmed SARS-CoV-2 should be done in NPV room [107]. However,
Cook et al. stated that the high air-exchange rates in the rooms were more important than
whether the rooms were under negative or positive pressure and they recommended that
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particles should be prevented from settling in places with a low rate of air exchange or no
ventilation [71]. Furthermore, Bhagat et al. performed a study about different forms of
ventilation, including mixing ventilation, natural and mechanical displacement ventilation,
and wind-driven ventilation [108]. Importantly, if displacement ventilation is designed
properly to promote vertical stratification, it can reduce indoor warm air pollutants close
to the ceiling [108]. Hence, displacement ventilation should be the most effective for
diminishing the exposure risk of SARS-CoV-2 and can be simply and cheaply installed via
vents or fans at the top of the space [108]. Instead, mixing ventilation disperses indoor air
throughout the space and cannot support any potentially clean zones [108].
Miller et al. evaluated the aerosol generation with noninvasive positive pressure
ventilation (NIPPV) and the high-flow nasal cannula (HFNC) in contrast to 6 L per minute
using low-flow nasal cannula in healthy volunteers [109]. The results show that NIPPV
and HFNC did not raise SARS-CoV-2 aerosol emissions in contrast to low-flow nasal
cannula in healthy volunteers [109]. Li and co-authors (2020) reported that production and
distribution of SARS-CoV-2 by HFNC can occur [86]. In addition, Li et al. explained that,
to control the production and distribution of SARS-CoV-2 aerosol from COVID-19 patients,
surgical masks can be put on the patient’s face and prong it with a high-flow nasal cannula
(HFNC) [86]. The protection approaches for transmissions of SARS-CoV-2 is described
in Section 4.5.
4.5. Protection Approaches for Transmissions of SARS-CoV-2
Due to the high prevalence of novel coronavirus in the world, precise control measures
for SARS-CoV-2 are needed [43–46]. Liao et al. reported that, during a choir practice
(singing), forty-five persons of a sixty-member choir group were exposed to SARS-CoV-2,
and two members died [67]. According to past work, the mean number of people an
individual transfers SARS-CoV-2 to is 2 ≤ R0 ≤ 2.5 [32]. Thus, local governments suggest
controlling the COVID-19 pandemic by practicing social distancing and staying at home
(virus source control) [23,32,38,61,63,94,110–115].
Efforts to control ventilation related spreading of the virus in restaurants, cruise ships,
nursing homes, schools, kindergartens, offices, shops, and public transport are essential
to controlling the pandemic [45,116]. Particular individuals with high levels of infection
should be restricted from human-to-human contact and polluting the environment to pro-
tect others [13,60]. A simple and cost-effective way for preventing SARS-CoV-2 distribution
is by everyone to wear protective masks in public places [10,23,45,50,117,118]. While surgi-
cal masks can decrease the spread of COVID-19 [12], N95 masks are needed by workers in
healthcare facilities combined with gowns and goggles [12,50]. Additionally, Fiorillo et al.
suggested that health care workers must be protected from the contact with the patient’s
aerosol with filtering facepiece particles masks (FFP) of type FFP2 and FFP3 [74] of similar
performance to N95 and N99 masks in the United States, respectively. In the case of surgical
mask, their filtration efficiency only protects the user against droplet nuclei of size larger
than 2 µm [65]. In general, face coverings are more effective for decreasing the direct
ejection of breath and bioaerosols away from the user [108]. Disinfection of surfaces, i.e.,
with suitable detergents, along with frequent hand washing and using of appropriate
personal protective equipment are important preventive measures to decrease SARS-CoV-2
transmission [74].
In addition to proper ventilation, cleaning methods such as mechanical air filters,
ultra-violet germicidal irradiation (UVGI), high-efficiency particulate air (HEPA) filters
and ion generators, and even other chemical methods such as alcohol, hydrogen peroxide,
and sodium hypochlorite cab be used for deactivating coronaviruses [9,78,119]. For exam-
ple, isopropyl and ethyl alcohol have been applied as disinfectants in healthcare settings
in recent years [120]. Previous studies demonstrated that 60–70% solutions of ethyl alco-
hol can deactivate murine norovirus, Ebola virus, and many coronaviruses [47,120,121].
However, due to the airborne distribution of SARS-CoV-2, disinfection of ambient air
in communities and cities appears more challenging as high levels of alcohol and other
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disinfectants in air are a potentially danger for people [12]. Hence, the use of chemical
disinfection methods and face masks appear as the most appropriate measures for limiting
the spreading of this pandemic [12,45,59].
Although some countries are developing and starting to implement the use of vaccines
at present, many nations can only implement preventive measures and effective health
responses by government officials, medical doctors, and the public to restrict the spread of
COVID-19. In addition to other modes of transmission of SARS-CoV-2, person-to-person
transmission of SARS-CoV-2 is a serious threat to public health due to its fast dissemination
in public gatherings [122]. Some important steps needed to prevent the spreading of
COVID-19 are:
(1) Isolation of the affected persons, including asymptomatic carriers and travelers from
affected countries [122]
(2) Applying travel restrictions from and to infected countries [122]
(3) Avoiding social gatherings and events [122]
(4) Extending knowledge of the public awareness about COVID-19 [122]
(5) Wearing of personal protective equipment, especially masks, such as N95, FFP2,
and FFP3, along with hand washing and using of appropriate protective clothes by
healthcare workers [12,50,74,122]
(6) Ensuring measures to boost the immune system such as consuming nutrient with
suitable vitamins such as C and E [122,123]
(7) Keeping social distancing (about 1.5–3 m) [23,32,49,70,122]
(8) Applying proper ventilation such as displacement ventilation [103,108]
Summarizing, to limit airborne and droplet transmissions of SARS-CoV-2, the fol-
lowing are recommended: (i) adequate ventilation or good air-conditioning systems for
rooms [45,46,78,94,103]; (ii) appropriate disinfection of toilets [46]; (iii) the use of open
space with minimum crowds [46]; (iv) utilization of negative pressure rooms [24,103];
(v) screening and testing of individuals suspected of carrying SARS-CoV-2 [46,124,125];
(vi) monitoring temperature at close space such as restaurant [94]; (vii) keeping a cau-
tionary distance to others [32,45,71,98]; (viii) avoiding the direct airflow of others [45,126];
(ix) reducing the number of individuals in a common place for minimizing sharing indoor
air [45,127]; and (x) minimizing the number of shared devices and objects with other
people [45,71,72].
5. Conclusions
COVID-19 has become a global health concern creating severe respiratory tract infec-
tions and other complications. The pathways of probable transmission of SARS-CoV-2
considered in this work include direct contact, airborne, fecal–oral, and droplet transmis-
sion routes. The influence of negative pressure ventilation and air conditioning systems on
the airborne transmission was discussed. The major findings of this work are:
• The airborne transmission of SARS-CoV-2 is an important contributor to fast spreading
of the associated disease.
• Droplet transmission occurs from particles >5 µm, which can settle on surfaces under
gravitational settling and do not move more than 1 m. Particles <5 µm can stay
suspended for an extended period of time (≥2 h) and travel longer distances (up to
8 m) through simple diffusion and convection mechanisms.
• The environmental ambient conditions can affect airborne transmission of SARS-CoV-2
over larger distances.
• The droplets <10 µm in size can be transferred larger distant when the weather is cold
and humid.
• The persistence of the virus is remarkable at a low temperature (4 ◦C), and, by raising
the temperature to 70 ◦C, the virus was no longer detectable after 5 min.
• Although warm weather can slow down the growth rates of SARS-CoV-2, rigid social
enforcement and other measures such as the widespread use of face masks are still
needed to control the COVID-19 pandemic.
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• Coordinated measures among the public and private sectors are needed to control
this disease at the national and international level. Joint solutions from different
experts, not only in the biomedical sciences, but also in the environment, chemistry,
physics, public health, and areas covering transportation, immigration, economic
affairs, and education, are required.
• SARS-CoV-2 can also be resuspended from floor surfaces and from protective clothes
and shoes of medical workers in indoor environments. Indeed, direct contact with
fomites is not the only way for causing viral infection with SARS-CoV-2. As explained
above, SARS-CoV-2 is distributed via air. Thus, disinfection of surfaces and protective
equipment before removal is needed together with frequent hand washing.
• The various coronaviruses survive on surfaces for up to nine days, and they can be
eliminated by disinfection with 62–71% ethanol for 1 min or 0.1% sodium hypochlorite.
• Healthcare workers must be provided with N95, FFP2, or FFP3 masks combined with
gowns and goggles.
• Overall, control measures such as using high adequate ventilation, rooms with neg-
ative pressure ventilation, practicing social distancing, and wearing N95 and even
surgical facemasks are potentially suggested to reduce the SARS-CoV-2 airborne
transmission.
5.1. Future Perspective
Future experimental work is certainly needed to expand the current understanding of
the findings reported above and on other modes of SARS-CoV-2 transmission by water,
wastewater (sewage), and infectious solid waste. In addition, in-depth studies should be
performed to explain the effect of air pollution, e.g., PM2.5, PM10, SO2, NO2, Pb, VOCs,
and CO, on the airborne and fomite transmission of SARS-CoV-2 to diverse populations.
Studying the influence of sunny, rainy, and smog days on the transmission modes of
SARS-CoV-2 should be of interest to characterize different scenarios for airborne and
fomite transmissions.
5.2. Capsule
This work is novel in that there are no reports to our knowledge of the modes of
transmission of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) and factors
influencing on the airborne transmission. The results of this work have broad implications
for people around the world owing to the pervasiveness of Coronavirus Disease 2019
(COVID-19).
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